Standard
Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas. / Olsen, I. H.; Federspiel, B.; Kjaer, A.; Hansen, Carsten Palnæs; Knigge, U.; Langer, S. W.
2011. 38-38 Abstract fra 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease, Lisbon, Portugal.
Publikation: Konferencebidrag › Konferenceabstrakt til konference › Forskning › fagfællebedømt
Harvard
Olsen, IH, Federspiel, B, Kjaer, A, Hansen, CP, Knigge, U & Langer, SW 2011, 'Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas', 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease, Lisbon, Portugal, 09/03/2011 - 11/03/2011 s. 38-38.
APA
Olsen, I. H., Federspiel, B., Kjaer, A., Hansen, C. P., Knigge, U., & Langer, S. W. (2011). Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas. 38-38. Abstract fra 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease, Lisbon, Portugal.
Vancouver
Olsen IH, Federspiel B, Kjaer A, Hansen CP, Knigge U, Langer SW. Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas. 2011. Abstract fra 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease, Lisbon, Portugal.
Author
Olsen, I. H. ; Federspiel, B. ; Kjaer, A. ; Hansen, Carsten Palnæs ; Knigge, U. ; Langer, S. W. / Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas. Abstract fra 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease, Lisbon, Portugal.1 s.
Bibtex
@conference{95689dadd578486ba98940f2d757f40c,
title = "Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas",
author = "Olsen, {I. H.} and B. Federspiel and A. Kjaer and Hansen, {Carsten Paln{\ae}s} and U. Knigge and Langer, {S. W.}",
year = "2011",
language = "English",
pages = "38--38",
note = "8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease ; Conference date: 09-03-2011 Through 11-03-2011",
}
RIS
TY - ABST
T1 - Temozolomide as 2nd-3rd Line Treatment of Patients with Poorly Differentiated Neuroendocrine Carcinomas
AU - Olsen, I. H.
AU - Federspiel, B.
AU - Kjaer, A.
AU - Hansen, Carsten Palnæs
AU - Knigge, U.
AU - Langer, S. W.
PY - 2011
Y1 - 2011
M3 - Conference abstract for conference
SP - 38
EP - 38
T2 - 8th Annual ENETS Conference for the Diagnosis and Treatment of Neuroendocine Tumor Disease
Y2 - 9 March 2011 through 11 March 2011
ER -
